S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 94.9 TWD -1.15% Market Closed
Market Cap: 11.3B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SCI Pharmtech Inc
Total Equity Peer Comparison

Comparables:
Y
3705
4746
1789
1795
1720

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Total Equity
NT$5.1B
CAGR 3-Years
15%
CAGR 5-Years
10%
CAGR 10-Years
9%
Y
YungShin Global Holding Corp
TWSE:3705
Total Equity
NT$7.4B
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
3%
Formosa Laboratories Inc
TWSE:4746
Total Equity
NT$7.5B
CAGR 3-Years
-1%
CAGR 5-Years
12%
CAGR 10-Years
11%
ScinoPharm Taiwan Ltd
TWSE:1789
Total Equity
NT$10.4B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Total Equity
NT$17.2B
CAGR 3-Years
17%
CAGR 5-Years
17%
CAGR 10-Years
22%
Standard Chem & Pharm Co Ltd
TWSE:1720
Total Equity
NT$5.8B
CAGR 3-Years
13%
CAGR 5-Years
10%
CAGR 10-Years
7%

See Also

What is SCI Pharmtech Inc's Total Equity?
Total Equity
5.1B TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Total Equity amounts to 5.1B TWD.

What is SCI Pharmtech Inc's Total Equity growth rate?
Total Equity CAGR 10Y
9%

Over the last year, the Total Equity growth was 23%. The average annual Total Equity growth rates for SCI Pharmtech Inc have been 15% over the past three years , 10% over the past five years , and 9% over the past ten years .

Back to Top